BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 17680991)

  • 1. Cone arrestin binding to JNK3 and Mdm2: conformational preference and localization of interaction sites.
    Song X; Gurevich EV; Gurevich VV
    J Neurochem; 2007 Nov; 103(3):1053-62. PubMed ID: 17680991
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Visual and both non-visual arrestins in their "inactive" conformation bind JNK3 and Mdm2 and relocalize them from the nucleus to the cytoplasm.
    Song X; Raman D; Gurevich EV; Vishnivetskiy SA; Gurevich VV
    J Biol Chem; 2006 Jul; 281(30):21491-21499. PubMed ID: 16737965
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Arrestin mobilizes signaling proteins to the cytoskeleton and redirects their activity.
    Hanson SM; Cleghorn WM; Francis DJ; Vishnivetskiy SA; Raman D; Song X; Nair KS; Slepak VZ; Klug CS; Gurevich VV
    J Mol Biol; 2007 Apr; 368(2):375-87. PubMed ID: 17359998
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mouse cone arrestin expression pattern: light induced translocation in cone photoreceptors.
    Zhu X; Li A; Brown B; Weiss ER; Osawa S; Craft CM
    Mol Vis; 2002 Dec; 8():462-71. PubMed ID: 12486395
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of arrestin-3-specific residues necessary for JNK3 kinase activation.
    Seo J; Tsakem EL; Breitman M; Gurevich VV
    J Biol Chem; 2011 Aug; 286(32):27894-901. PubMed ID: 21715332
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The beta-arrestin-2 scaffold protein promotes c-Jun N-terminal kinase-3 activation by binding to its nonconserved N terminus.
    Guo C; Whitmarsh AJ
    J Biol Chem; 2008 Jun; 283(23):15903-11. PubMed ID: 18408005
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Crystal structure of cone arrestin at 2.3A: evolution of receptor specificity.
    Sutton RB; Vishnivetskiy SA; Robert J; Hanson SM; Raman D; Knox BE; Kono M; Navarro J; Gurevich VV
    J Mol Biol; 2005 Dec; 354(5):1069-80. PubMed ID: 16289201
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dynamic interaction between the dual specificity phosphatase MKP7 and the JNK3 scaffold protein beta-arrestin 2.
    Willoughby EA; Collins MK
    J Biol Chem; 2005 Jul; 280(27):25651-8. PubMed ID: 15888437
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Arrestin-3 binds the MAP kinase JNK3α2 via multiple sites on both domains.
    Zhan X; Perez A; Gimenez LE; Vishnivetskiy SA; Gurevich VV
    Cell Signal; 2014 Apr; 26(4):766-76. PubMed ID: 24412749
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structural Mechanism of the Arrestin-3/JNK3 Interaction.
    Park JY; Qu CX; Li RR; Yang F; Yu X; Tian ZM; Shen YM; Cai BY; Yun Y; Sun JP; Chung KY
    Structure; 2019 Jul; 27(7):1162-1170.e3. PubMed ID: 31080119
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Silent scaffolds: inhibition OF c-Jun N-terminal kinase 3 activity in cell by dominant-negative arrestin-3 mutant.
    Breitman M; Kook S; Gimenez LE; Lizama BN; Palazzo MC; Gurevich EV; Gurevich VV
    J Biol Chem; 2012 Jun; 287(23):19653-64. PubMed ID: 22523077
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Short Arrestin-3-Derived Peptides Activate JNK3 in Cells.
    Perry-Hauser NA; Kaoud TS; Stoy H; Zhan X; Chen Q; Dalby KN; Iverson TM; Gurevich VV; Gurevich EV
    Int J Mol Sci; 2022 Aug; 23(15):. PubMed ID: 35955810
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Arrestins as multi-functional signaling adaptors.
    Gurevich VV; Gurevich EV; Cleghorn WM
    Handb Exp Pharmacol; 2008; (186):15-37. PubMed ID: 18491047
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Few residues within an extensive binding interface drive receptor interaction and determine the specificity of arrestin proteins.
    Vishnivetskiy SA; Gimenez LE; Francis DJ; Hanson SM; Hubbell WL; Klug CS; Gurevich VV
    J Biol Chem; 2011 Jul; 286(27):24288-99. PubMed ID: 21471193
    [TBL] [Abstract][Full Text] [Related]  

  • 15. GPCR Binding and JNK3 Activation by Arrestin-3 Have Different Structural Requirements.
    Zheng C; Weinstein LD; Nguyen KK; Grewal A; Gurevich EV; Gurevich VV
    Cells; 2023 Jun; 12(12):. PubMed ID: 37371033
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Arrestin-dependent activation of JNK family kinases.
    Zhan X; Kook S; Gurevich EV; Gurevich VV
    Handb Exp Pharmacol; 2014; 219():259-80. PubMed ID: 24292834
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential nucleocytoplasmic shuttling of beta-arrestins. Characterization of a leucine-rich nuclear export signal in beta-arrestin2.
    Scott MG; Le Rouzic E; Périanin A; Pierotti V; Enslen H; Benichou S; Marullo S; Benmerah A
    J Biol Chem; 2002 Oct; 277(40):37693-701. PubMed ID: 12167659
    [TBL] [Abstract][Full Text] [Related]  

  • 18. How does arrestin assemble MAPKs into a signaling complex?
    Song X; Coffa S; Fu H; Gurevich VV
    J Biol Chem; 2009 Jan; 284(1):685-695. PubMed ID: 19001375
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A scanning peptide array approach uncovers association sites within the JNK/beta arrestin signalling complex.
    Li X; MacLeod R; Dunlop AJ; Edwards HV; Advant N; Gibson LC; Devine NM; Brown KM; Adams DR; Houslay MD; Baillie GS
    FEBS Lett; 2009 Oct; 583(20):3310-6. PubMed ID: 19782076
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ubiquitin ligase parkin promotes Mdm2-arrestin interaction but inhibits arrestin ubiquitination.
    Ahmed MR; Zhan X; Song X; Kook S; Gurevich VV; Gurevich EV
    Biochemistry; 2011 May; 50(18):3749-63. PubMed ID: 21466165
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.